Corporate News
Eva Live (ticker GOAI) experienced a decline of 3.23 % during the 24‑hour period that concluded at 03:50 AM Central Europe on Wednesday, 21 September 2026. The share price settled at USD 1.44 on major exchanges, a level that reflects a modest valuation relative to the company’s current market capitalisation of USD 62.8 million. With an outstanding supply of 40.5 million shares, the trading volume for the last 24 hours was USD 36.2 k, indicating a relatively low liquidity profile.
Over the longer term, Eva Live has seen a sharper decline: since the end of the previous month the stock has fallen 14.29 %. The 200‑day simple moving average sits at USD 3.37, underscoring the downward trend that has characterised the company’s performance in recent months. In contrast, the 52‑week high reached USD 18 on 28 January 2026, while the 52‑week low was USD 1.42 on 11 August 2026, signalling considerable volatility.
Comparison with Peer Stocks
| Company | Recent Performance | Current Price (USD) | Market Capitalisation (USD mn) | P/E Ratio |
|---|---|---|---|---|
| Northern (NTIC) | +0.13 % | 7.70 | 73.2 | – |
| Pulmonx (LUNG) | –1.69 % | 1.82 | 74.1 | – |
| Calisa Acquisition (ALIS) | +2.43 % | 9.03 | 74.5 | 112.8 |
| Air T (AIRT) | –4.49 % | 26.48 | 75.2 | 1.22 |
| Outset Medical (OM) | –3.55 % | 4.22 | 74.1 | – |
The table shows that, while some peers such as Northern and Calisa Acquisition have posted modest gains, others—including Pulmonx, Air T, and Outset Medical—have also experienced declines in the last day. Calisa Acquisition’s high price‑to‑earnings ratio of 112.8 reflects a valuation that may be driven by growth expectations or market speculation, whereas Air T’s low P/E of 1.22 suggests a more conservative valuation approach.
Company Overview
Eva Live Inc. is listed on the OTC Bulletin Board, a component of the United States stock market system that facilitates trading of securities not listed on the main exchanges. The company’s public status allows it to raise capital through equity markets, though it currently trades at a price that is a fraction of its historical peaks. Investors should note the company’s modest trading volume and the sharp decline in its share price over the last month, which together may indicate a period of market reassessment or strategic realignment.
This article is intended to provide an objective overview of Eva Live’s recent performance and contextualise it within the broader sector.